
Strive Health is the nation’s leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of technology-enabled care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 121,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive’s case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST. To learn more, visit StriveHealth.com.

Strive Health is the nation’s leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of technology-enabled care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 121,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive’s case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST. To learn more, visit StriveHealth.com.
Domain: Value-based kidney care for CKD and ESKD
Headquarters: Denver, Colorado
Scale: Serves ~121,000 patients across all 50 U.S. states
Tech & Accreditations: AI-enabled platform; CareMultiplier™; HITRUST and NCQA certifications
Recent major funding: Series C $166M (May 31, 2023); total funding reported ~ $606M
Chronic kidney disease (CKD) progression, end-stage kidney disease (ESKD) management, and reducing cost and utilization in renal care through value-based models.
2018
Hospitals and Health Care
140000000
166000000
“Backed by NEA and CapitalG with participation from strategic investors including CVS Health Ventures, Echo Health Ventures, Ascension Ventures, Town Hall Ventures, and Redpoint”
| Company |
|---|